GlassScriptPhysician profile
Melissa Dawn Manson
NPI 1649887902
$1,584.67
in general payments reported to CMS, 2019-2025
16 companies · $9.33 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.33 · 2023: $830 · 2024: $729 · 2025: $9.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486 · Education: $82.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.59 |
| Education | $82.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $670.49 | 2023-2024 | |
| Amgen INC. | $189.74 | 2023-2024 | Tavneos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.04 | 2023 | Jardiance |
| Opko Pharmaceuticals, LLC | $99.08 | 2022-2024 | Rayaldee |
| Astrazeneca Pharmaceuticals LP | $82.27 | 2023-2024 | Lokelma, Farxiga |
| Novartis Pharmaceuticals Corporation | $77.29 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $69.73 | 2023 | Acthar |
| Calliditas Therapeutics US INC. | $57.64 | 2023-2024 | Tarpeyo |
| Alexion Pharmaceuticals, INC. | $48.52 | 2023-2024 | Ultomiris |
| Renalytix Ai, INC. | $37.29 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Outset Medical INC | $30.36 | 2024 | |
| Travere Therapeutics, INC. | $28.83 | 2024-2025 | |
| Ultragenyx Pharmaceutical INC. | $24.17 | 2023 | |
| Ardelyx, INC. | $18.58 | 2024 | Ibsrela |
| Nxstage Medical, INC. | $16.59 | 2023 | Liberty Select Cycler, Nxstage System One |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.05 | 2024 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Manson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.